Skip to content
FDAMedical devices

Nova Biomedical® Announces Global Medical Device Correction for StatStrip® Glucose Hospital Meter

FDA recall n-nova-biomedicalr-announces-global-medical-device-correction-statstripr-glucose-h ·

Build snapshot. Collected , once, when this site was built. It is not a live feed.

Check my lot or code

Is yours in this recall?

Type the lot, batch, date code, model number or UPC printed on the product. It is compared here, in your browser, with the codes this notice lists. It stays in this page: it is not added to the address.

General information on recalls from the agency: U.S. Food and Drug Administration (opens in a new tab).

What the agency says to do

FDA’s record gives no instruction for consumers.

Note from Recalls Watch, not agency text

Why it was recalled

Software issue may cause a glucose result to be associated to the wrong patient
Text from FDA, unedited.

The recalled product

WALTHAM, Mass., October 5, 2026 – Nova Biomedical initiated a global Medical Device Correction on July 24, 2026, for the StatStrip® Glucose Hospital Meter System due to a software issue that may cause a glucose result to be associated with the wrong patient. When a patient ID barcode is scanned, pri
Text from FDA, unedited.

Company announcement, as FDA publishes it

WALTHAM, Mass., October 5, 2026 – Nova Biomedical initiated a global Medical Device Correction on July 24, 2026, for the StatStrip® Glucose Hospital Meter System due to a software issue that may cause a glucose result to be associated with the wrong patient. When a patient ID barcode is scanned, prior patient information may remain on the meter screen, which if accepted, will lead to glucose result being assigned to the wrong patient’s medical record. If not recognized, healthcare providers may make clinical decisions based on another patient’s glucose result, potentially leading to delayed treatment, unnecessary treatment (including inappropriate insulin administration), and/or failure to treat the intended patient. The severity of harm depends on the patient’s actual glucose status and clinical condition.

This issue only applies to the most recent model of the StatStrip Glucose Hospital Meter System, commonly referred to as the “Gen 2.0” model. This issue does not affect previously released models of the StatStrip Glucose Hospital Meter system, commonly referred to as the “Gen 1.0”, “Gen 1.75”,” “Gen 1.86”, or “Gen 1.87” StatStrip Glucose Hospital Meter systems.

On July 17, 2026, prior to the recall initiation, Nova Biomedical received one (1) report of an adverse event (AE) in the U.S. (none outside of the U.S.) associated with this issue. This AE involved inappropriate insulin administration to a patient based on a different patient's glucose results. No serious adverse events related to this issue have been reported. Affected products. This recall applies to all serial numbers of the products listed below:

As a precautionary measure, Nova has implemented a shipment hold on all StatStrip Glucose Hospital Meter Systems while corrective actions are being developed and validated. Efforts are underway for the verification and validation of a software update to address this issue. Nova intends to roll out the software update in November 2026 in a phased manner. This will include measures to mitigate the issues related to the recall, as well as other non-safety-related improvements.

While this software update will mitigate known contributing factors associated with the recall, Nova will continue to monitor the performance of the StatStrip Hospital Glucose System and evaluate opportunities for additional improvements as appropriate.

While working on resolution to the patient ID issue, Nova is providing the following recommendations to end users:

To mitigate the risk of glucose results being assigned to the wrong patient’s medical record, Nova recommends the use of patient validation and operator log o software configurations available in current Statstrip Glucose Hospital meter system and NovaNet middleware.

After every barcode scan, verify on the device that the patient ID displayed is for the patient currently being tested. Confirm that the patient name, date of birth, and other identifying information shown on the Confirm Patient ID screen correspond to the patient whose sample is being collected before pressing Accept. When the glucose result populates on the device after testing is complete, verify again that the patient ID displayed on the result screen belongs to the patient currently being tested. Do not assume that the patient ID displayed at the time of result is the same as the one verified at the time of scanning.

If any glucose level is assigned to the incorrect patient, immediately notify your administrator. If you do not have an alternative device, you must continue to follow these mitigation steps until the software fix becomes available. If you have an alternative device, you should stop using the affected device.

More information about the Global Medical Device Correction for the StatStrip® Glucose Hospital Meter System, including detailed instructions for customers or individuals with an affected StatStrip meter can be found on the Nova Biomedical website here: https://www.novabiomedical.com/statstrip-global-medical-device-correction/ .

Customer support. Customers in the United States may contact Nova Biomedical Technical Support at 1-800-545-6682. Customers in Canada may call 1-800-263-5999. Technical Support is available 24 hours a day, 7 days a week, 365 days a year. Customers outside the United States or Canada should contact their authorized Nova Biomedical distributor or local sales representative.

Reporting Adverse Events:

Healthcare professionals and customers should report adverse events or product quality problems associated with these devices to Nova Biomedical. Adverse events may also be reported to the FDA MedWatch Adverse Event Reporting Program in accordance with FDA instructions.

Online: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverseevent-reporting-program

Mail or Fax: Download forms online: https://www.fda.gov/safety/medical-productsafety-information/medwatch-forms-fda-safety-reporting or call the MedWatch Safety Reporting Hotline at1-800-332-1088 to request a form. Mail or fax the form to the FDA contact information provided on the form.

###

About Nova Biomedical

Nova Biomedical develops measurement technologies that give scientists and healthcare professionals the information they need to make critical decisions. The company’s clinical business develops diagnostic technologies for hospital laboratories, critical care, point-of-care, and other patient-care settings. Its portfolio includes whole-blood analysis, glucose and ketone testing, osmolality, cerebrospinal fluid cell counting, and liquid-handling verification, helping healthcare teams obtain reliable results quickly and make informed treatment decisions. Headquartered in Waltham, Massachusetts, Nova Biomedical serves customers in more than 120 countries. For more information, visit novabiomedical.com .

Text from FDA (the company’s words), unedited.
  • StatStrip Glucose Hospital Meter System

    Lot or code
    Nova part ; number: 63685; Device identifier ; (UDI): 00385480636858; Distribution: U.S., Global
  • StatStrip Glucose Hospital Meter System (Multipack)

    Lot or code
    Nova part ; number: 66739; Device identifier ; (UDI): 00385480636858; Distribution: U.S., Global
  • StatStrip Glucose and β-Ketone Meter

    Lot or code
    Nova part ; number: 63683; Device identifier ; (UDI): 00385480636834; Distribution: Global (excluding U.S.) | Nova part ; number: 63726; Device identifier ; (UDI): 00385480637268; Distribution: Japan
  • StatStrip Glucose and β-Ketone Meter (UK/Canada version)

    Lot or code
    Nova part ; number: 63910; Device identifier ; (UDI): 00385480639101; Distribution: Global (excluding U.S.)
  • StatStrip Glucose and β-Ketone Meter (Rilibäk)

    Lot or code
    Nova part ; number: 66249; Device identifier ; (UDI): 00385480664295; Distribution: Germany

Source

Issued by
U.S. Food and Drug Administration
Firm
Nova Biomedical

Check all notices that name this firm in the directory of recalls by brand and manufacturer. This notice is in these lists: Month: October 2026, Week 2026-W41. Browse more medical devices recalls, or check another notice by its number in the recall number lookup.

About this recall

What is the hazard?

FDA states: “Software issue may cause a glucose result to be associated to the wrong patient”

What should I do if I have this product?

FDA’s record gives no instruction for consumers. The official report is linked on this page.

How do I know if my product is included?

Compare the lot or code printed on your product with the codes FDA lists on this notice, product by product.

How does the code check on this page work?

You type the lot, batch, date code, model number or UPC from your package and the page compares it, in your browser, with the codes FDA lists on this notice. It reports a match, a possible match (your code is part of a longer listed code) or no match. It only compares text: a notice that describes products by dates, sizes or “all lots” cannot be compared, so “no match” does not clear a product. The comparison runs in your browser and the page does not send the code anywhere, and the code stays out of the page address. Only if you press “Copy link to this result” is a link made that carries it, and whoever opens that link requests that address from this site.

When was this recall published?

FDA published this company announcement on October 5, 2026.